These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16918073)
1. Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes. Pires VS; Gaboriau F; Guillon J; Nascimento S; Dassonville A; Lescoat G; Desplat V; Rochette J; Jarry C; Sonnet P J Enzyme Inhib Med Chem; 2006 Jun; 21(3):261-70. PubMed ID: 16918073 [TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Rouge P; Pires VS; Gaboriau F; Dassonville-Klimpt A; Guillon J; Nascimento SD; Leger JM; Lescoat G; Sonnet P J Enzyme Inhib Med Chem; 2010 Apr; 25(2):216-27. PubMed ID: 19883235 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II. Latxague L; Gaboriau F; Chassande O; Leger JM; Pires V; Rouge P; Dassonville-Klimpt A; Fardeau S; Jarry C; Lescoat G; Guillon J; Sonnet P J Enzyme Inhib Med Chem; 2011 Apr; 26(2):204-15. PubMed ID: 20545489 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism. Lescoat G; Chantrel-Groussard K; Pasdeloup N; Nick H; Brissot P; Gaboriau F Cell Prolif; 2007 Oct; 40(5):755-67. PubMed ID: 17877614 [TBL] [Abstract][Full Text] [Related]
5. The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox. Chantrel-Groussard K; Gaboriau F; Pasdeloup N; Havouis R; Nick H; Pierre JL; Brissot P; Lescoat G Eur J Pharmacol; 2006 Jul; 541(3):129-37. PubMed ID: 16765341 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities. An L; Wang C; Zheng YG; Liu JD; Huang TH Eur J Med Chem; 2021 Jan; 210():112984. PubMed ID: 33183867 [TBL] [Abstract][Full Text] [Related]
7. Improvement of the Anticancer Activity of Chlorambucil and Ibuprofen via Calix[4]arene Conjugates. Pedro-Hernández LD; Organista-Mateos U; Allende-Alarcón LI; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M Med Chem; 2020; 16(7):984-990. PubMed ID: 31448714 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Crystal Structure, and Biological Activity of a Multidentate Calix[4]arene Ligand Doubly Functionalized by 2-Hydroxybenzeledene-Thiosemicarbazone. Bahojb Noruzi E; Shaabani B; Geremia S; Hickey N; Nitti P; Kafil HS Molecules; 2020 Jan; 25(2):. PubMed ID: 31963211 [TBL] [Abstract][Full Text] [Related]
9. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study. Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465 [TBL] [Abstract][Full Text] [Related]
10. Development of tridentate iron chelators: from desferrithiocin to ICL670. Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677 [TBL] [Abstract][Full Text] [Related]
11. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG. Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator. Salehi S; Saljooghi ASh; Shiri A Eur J Pharmacol; 2016 Jun; 781():209-17. PubMed ID: 27090924 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures. Lescoat G; Léonce S; Pierré A; Gouffier L; Gaboriau F Chem Biol Interact; 2012 Jan; 195(2):165-72. PubMed ID: 22197641 [TBL] [Abstract][Full Text] [Related]
14. Chelation of thallium by combining deferasirox and desferrioxamine in rats. Saljooghi AS; Babaie M; Mendi FD; Zahmati M; Saljooghi ZS Toxicol Ind Health; 2016 Jan; 32(1):83-8. PubMed ID: 24021432 [TBL] [Abstract][Full Text] [Related]
15. Narrow-rim functionalization of calix[4]arene through Ugi-4CR: synthesis of a series of calix[4]arene peptoids. Savithri A; Thulasi S; Varma RL J Org Chem; 2014 Feb; 79(4):1683-9. PubMed ID: 24498973 [TBL] [Abstract][Full Text] [Related]
16. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes. Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630 [TBL] [Abstract][Full Text] [Related]
17. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo. Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255 [TBL] [Abstract][Full Text] [Related]